drugset / Trial / NCT00017004
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Phase 3
Completed
114 enrolled
Gynecologic Oncology Group
Canadian Cancer Trials Group · collabNational Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Epoetin alfa may stimulate red blood cell production to treat anemia in patients who have received chemotherapy and/or radiation therapy for cervical cancer. Randomized phase III trial to study the effectiveness of epoetin alfa in treating anemia in patients who have cervical cancer.
Timeline
- Start
- 2001-08
- Primary completion
- 2004-05-15
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | — | Subcutaneous |
| Background | Cisplatin | Other / unclassified | — | Intravenous |